IHC of paraffin-embedded Carcinoma of Human bladder tissue using anti-ACBD3 mouse monoclonal antibody.
IHC of paraffin-embedded Carcinoma of Human lung tissue using anti-ACBD3 mouse monoclonal antibody.
IHC of paraffin-embedded Human pancreas tissue using anti-ACBD3 mouse monoclonal antibody.
IHC of paraffin-embedded Human prostate tissue using anti-ACBD3 mouse monoclonal antibody.
IHC of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-ACBD3 mouse monoclonal antibody.
IHC of paraffin-embedded Carcinoma of Human liver tissue using anti-ACBD3 mouse monoclonal antibody.
IHC of paraffin-embedded Human tonsil using anti-ACBD3 mouse monoclonal antibody.
IHC of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-ACBD3 mouse monoclonal antibody.
IHC of paraffin-embedded Human breast tissue using anti-ACBD3 mouse monoclonal antibody.
IHC of paraffin-embedded Human liver tissue using anti-ACBD3 mouse monoclonal antibody.
IHC of paraffin-embedded Human colon tissue using anti-ACBD3 mouse monoclonal antibody.
Western blot of extracts (35 ug) from 9 different cell lines by using anti-ACBD3 monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ACBD3 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ACBD3.
Flow cytometry of Jurkat cells, using anti-ACBD3 antibody (Red), compared to a nonspecific negative control antibody (Blue).
HEK293T cells transfected with either overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-ACBD3 antibody, and then analyzed by flow cytometry.